Two Sigma Advisers’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-330,887
Closed -$7.85M 2697
2023
Q3
$7.85M Sell
330,887
-20,600
-6% -$388K 0.02% 560
2023
Q2
$5.7M Sell
351,487
-46,000
-12% -$762K 0.01% 706
2023
Q1
$6.92M Buy
397,487
+4,200
+1% +$75.5K 0.02% 681
2022
Q4
$7.39M Buy
393,287
+79,100
+25% +$1.52M 0.02% 609
2022
Q3
$5.56M Sell
314,187
-11,500
-4% -$200K 0.02% 688
2022
Q2
$5.68M Buy
325,687
+5,700
+2% +$109K 0.02% 712
2022
Q1
$6.69M Sell
319,987
-83,700
-21% -$1.6M 0.02% 680
2021
Q4
$7.18M Buy
403,687
+72,400
+22% +$1.16M 0.02% 625
2021
Q3
$4.67M Sell
331,287
-2,600
-0.8% -$40.4K 0.01% 815
2021
Q2
$5.54M Buy
333,887
+174,500
+109% +$3.13M 0.01% 815
2021
Q1
$2.88M Sell
159,387
-10,400
-6% -$205K 0.01% 1097
2020
Q4
$3.1M Sell
169,787
-27,200
-14% -$431K 0.01% 1045
2020
Q3
$2.51M Sell
196,987
-9,802
-5% -$125K 0.01% 1045
2020
Q2
$2.27M Buy
206,789
+105,400
+104% +$1.09M 0.01% 1139
2020
Q1
$1.06M Buy
101,389
+60,100
+146% +$775K ﹤0.01% 1456
2019
Q4
$664K Sell
41,289
-3,200
-7% -$52.9K ﹤0.01% 1754
2019
Q3
$697K Sell
44,489
-22,400
-33% -$373K ﹤0.01% 1583
2019
Q2
$1.33M Sell
66,889
-35,200
-34% -$657K ﹤0.01% 1387
2019
Q1
$1.72M Buy
102,089
+100
+0.1% +$1.73K ﹤0.01% 1284
2018
Q4
$1.54M Sell
101,989
-22,447
-18% -$385K ﹤0.01% 1298
2018
Q3
$2.5M Sell
124,436
-39,900
-24% -$846K 0.01% 1128
2018
Q2
$3.21M Sell
164,336
-40,400
-20% -$639K 0.01% 1068
2018
Q1
$2.79M Sell
204,736
-40,300
-16% -$531K 0.01% 1083
2017
Q4
$3.33M Sell
245,036
-20,748
-8% -$298K 0.01% 1011
2017
Q3
$4.18M Buy
265,784
+190
+0.1% +$3.07K 0.01% 871
2017
Q2
$4.57M Buy
265,594
+958
+0.4% +$14.6K 0.02% 793
2017
Q1
$4.03M Buy
264,636
+16,364
+7% +$241K 0.01% 909
2016
Q4
$3.27M Buy
248,272
+104,183
+72% +$1.33M 0.01% 928
2016
Q3
$1.63M Buy
144,089
+500
+0.3% +$6K 0.01% 1118
2016
Q2
$1.71M Buy
143,589
+1,700
+1% +$22.9K 0.01% 927
2016
Q1
$2.16M Sell
141,889
-29,900
-17% -$454K 0.01% 776
2015
Q4
$2.77M Sell
171,789
-1,900
-1% -$27.7K 0.02% 647
2015
Q3
$2.17M Buy
173,689
+2,900
+2% +$39.8K 0.01% 714
2015
Q2
$2.83M Sell
170,789
-36,500
-18% -$588K 0.02% 665
2015
Q1
$3.31M Sell
207,289
-17,900
-8% -$296K 0.02% 595
2014
Q4
$3.51M Buy
225,189
+33,800
+18% +$494K 0.03% 606
2014
Q3
$2.63M Buy
191,389
+47,700
+33% +$724K 0.02% 718
2014
Q2
$2.31M Buy
143,689
+22,700
+19% +$359K 0.02% 757
2014
Q1
$2.04M Buy
120,989
+80,900
+202% +$1.47M 0.02% 758
2013
Q4
$844K Sell
40,089
-17,300
-30% -$390K 0.01% 1236
2013
Q3
$1.25M Buy
+57,389
New +$1.22M 0.01% 850

Other funds holding NXGN

Two Sigma Advisers's NXGN Position: Q4 2023 in Review

Two Sigma Advisers sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 330,887 shares — an estimated $7.85M sold.

Two Sigma Advisers first reported a position in NXGN in Q3 2013 and held it in 41 quarters. The position peaked at $7.85M in Q3 2023. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Two Sigma Advisers reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 330,887 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $7.85M.
  • Two Sigma Advisers first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2013 and held it in 41 quarters.
  • Two Sigma Advisers's NextGen Healthcare, Inc. Common Stock position peaked at $7.85M in Q3 2023.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Two Sigma Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.